EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

An erythrocyte macrocytosis by methotrexate is associated with early initiation of biologic or targeted synthetic agents in patients with rheumatoid arthritis

In-Woon Baek iD, Kyung-Su Park iD, Ki-Jo Kim iD

Journal of Rheumatic Diseases · 01.01.2025 · 32 (1) · 30-37

DOI: 10.4078/jrd.2024.0073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Rheumatic Diseases, online erschienen am 02.09.2024. Verfasst von In-Woon Baek und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ErythrocyteErythrocyte indicesMethotrexateRheumatoid arthritis

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea.
  • St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

ORCID-Profile: In-Woon Baek, Kyung-Su Park, Ki-Jo Kim

Zitieren

APA

Baek, I. W., Park, K. S., & Kim, K. J. (2025). An erythrocyte macrocytosis by methotrexate is associated with early initiation of biologic or targeted synthetic agents in patients with rheumatoid arthritis. Journal of Rheumatic Diseases, 32(1), 30-37. https://doi.org/10.4078/jrd.2024.0073

Vancouver

Baek IW, Park KS, Kim KJ. An erythrocyte macrocytosis by methotrexate is associated with early initiation of biologic or targeted synthetic agents in patients with rheumatoid arthritis. Journal of Rheumatic Diseases. 2025;32(1):30-37. doi:10.4078/jrd.2024.0073

BibTeX
@article{Baek2025,
  author = {Baek, In-Woon and Park, Kyung-Su and Kim, Ki-Jo},
  title = {An erythrocyte macrocytosis by methotrexate is associated with early initiation of biologic or targeted synthetic agents in patients with rheumatoid arthritis},
  journal = {Journal of Rheumatic Diseases},
  year = {2025},
  volume = {32},
  number = {1},
  pages = {30--37},
  doi = {10.4078/jrd.2024.0073}
}
Kostenlos starten →